当前位置:
X-MOL 学术
›
Adv. Healthcare Mater.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Cell Encapsulation: Enhanced In Vivo Vascularization of 3D‐Printed Cell Encapsulation Device Using Platelet‐Rich Plasma and Mesenchymal Stem Cells (Adv. Healthcare Mater. 19/2020)
Advanced Healthcare Materials ( IF 10.0 ) Pub Date : 2020-10-07 , DOI: 10.1002/adhm.202070071 Jesus Paez‐Mayorga , Simone Capuani , Marco Farina , Maria Luisa Lotito , Jean A. Niles , Hector F. Salazar , Jessica Rhudy , Lucas Esnaola , Corrine Ying Xuan Chua , Francesca Taraballi , Bruna Corradetti , Kathryn A. Shelton , Pramod N. Nehete , Joan E. Nichols , Alessandro Grattoni
Advanced Healthcare Materials ( IF 10.0 ) Pub Date : 2020-10-07 , DOI: 10.1002/adhm.202070071 Jesus Paez‐Mayorga , Simone Capuani , Marco Farina , Maria Luisa Lotito , Jean A. Niles , Hector F. Salazar , Jessica Rhudy , Lucas Esnaola , Corrine Ying Xuan Chua , Francesca Taraballi , Bruna Corradetti , Kathryn A. Shelton , Pramod N. Nehete , Joan E. Nichols , Alessandro Grattoni
In article number 2000670 by Alessandro Grattoni and co‐workers, vascularization of a subcutaneously implantable cell encapsulation platform is enhanced via enrichment with plateletrich plasma (PRP) and mesenchymal stem cells (MSCs) in rats and non‐human primates. Timepoint vascularity assessment demonstrates enrichment with PRP and MSCs increases blood vessel density and maturity inside the encapsulation devices, unveiling an optimal window for cell transplantation. Interspecies reproducibility points toward translatability of the technology.
中文翻译:
细胞包囊:使用富含血小板的血浆和间充质干细胞增强3D打印的细胞包囊装置的体内血管化作用(高级卫生保健杂志,19/2020)
在Alessandro Grattoni及其同事的文章2000670中,通过富含大鼠和非人类灵长类动物的血小板丰富的血浆(PRP)和间充质干细胞(MSC)来增强皮下植入的细胞封装平台的血管形成。时间点血管性评估表明,PRP富集,而MSC增加了封装设备内部的血管密度和成熟度,为细胞移植开辟了最佳窗口。种间可重复性指向该技术的可翻译性。
更新日期:2020-10-07
中文翻译:
细胞包囊:使用富含血小板的血浆和间充质干细胞增强3D打印的细胞包囊装置的体内血管化作用(高级卫生保健杂志,19/2020)
在Alessandro Grattoni及其同事的文章2000670中,通过富含大鼠和非人类灵长类动物的血小板丰富的血浆(PRP)和间充质干细胞(MSC)来增强皮下植入的细胞封装平台的血管形成。时间点血管性评估表明,PRP富集,而MSC增加了封装设备内部的血管密度和成熟度,为细胞移植开辟了最佳窗口。种间可重复性指向该技术的可翻译性。